CAMP CAMP4 Therapeutics Corporation
Healthcare$4.10-9.09%ClosedMarket Cap: $87.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.45
P/S
24.35
EV/EBITDA
0.02
DCF Value
$2.92
FCF Yield
-27.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.2%
Operating Margin
-1322.6%
Net Margin
-2193.7%
ROE
-194.7%
ROA
-81.8%
ROIC
-58.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.3M | 59.8% | $-13.1M | $-18.3M | $— | — |
| Q4 null | $348.0K | 100.0% | $-12.8M | $-40.3M | $— | — |
| FY null | $3.5M | 53.1% | $-52.1M | $-80.4M | $— | — |
| Q3 null | $795.0K | 47.7% | $-13.2M | $-15.1M | $— | — |
| Q2 null | $1.5M | 100.0% | $-13.0M | $-12.6M | $— | — |
| Q1 null | $858.0K | 100.0% | $-13.1M | $-12.4M | $— | — |
| Q4 null | $652.0K | 100.0% | $-14.0M | $-13.3M | $— | — |
| FY null | $652.0K | 100.0% | $-53.1M | $-51.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-13.5M | $-13.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-12.7M | $-12.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-12.9M | $-12.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-13.5M | $-13.0M | $-2.27 | — |